当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Alphanate, Antihemophilic Factor/von Willebrand Factor Complex (Human)
申请企业
Grifols Biologicals LLC
药品名称
Alphanate, Antihemophilic Factor/von Willebrand Factor Complex (Human)
承诺描述
Conduct a Postmarketing study to further evaluate safety and efficacy of the product in type 3 vWD patients undergoing major surgeries.
承诺状态描述
The study completion date has passed, and the study has not yet been completed